Improvement with Infliximab of a Disseminated Sarcoidosis in a Patient with Crohn’s Disease
Figure 2
Chest ((a), (d)) and abdominal ((b), (c), (e), and (f)) PET scan showing hypermetabolism in pulmonary, hepatosplenic, spinal, and intestinal lesions before treatment ((a), (b), and (c)), markedly decreasing after treatment ((d), (e), and (f)) except for the distal ileum.